Seroprevalence of IgG anti-Toxocara canis antibodies and anti-Fasciola sp antibodies in patients with urticaria

Basit Öğe Kaydı
dc.contributor.authorDal, T.
dc.contributor.authorCicek, M.
dc.contributor.authorUcmak, D.
dc.contributor.authorAkkurt, M.
dc.contributor.authorTekin, A.
dc.contributor.authorDal, M. S.
dc.contributor.authorTekin, R.
dc.date.accessioned2024-04-24T17:28:20Z
dc.date.available2024-04-24T17:28:20Z
dc.date.issued2013
dc.departmentDicle Üniversitesien_US
dc.description.abstractAims. Chronic urticaria (CU) is defined by recurrent episodes occurring at least twice a week for 6 weeks and generally characterized by the rapid appearance of wheals and/or angioedema and may be associated with parasitic infections. We aimed to investigate the seroprevalance of Toxocara canis and Fasciola species in patients with CU. Materials and Methods. We included 55 patients (in age 16-55) with urticaria admitted in study. As a control group we recruited 30 healthy volunteers they had no history of urticaria, rhinitis, asthma, atopic eczema/dermatitis syndrome (AEDS), or other relevant diseases. IgG antibodies to Toxocara canis and Fasciola species were investigated by ELISA method. Results. In a total of 55 patients (mean age: 31.85 +/- 8.92), 8 patients (14.5%) were positive for IgG antibodies to Toxocara canis. Among seropositive patients (mean age: 38.62 +/- 12.46) 6 patients were female. No patient was positive for Fasciola by ELISA. Six of Toxocara canis seropositive cases were frequently visited or lived in rural areas and had contact with pets. Conclusions. Patients with urticaria, should be tested for Toxocara canis and treated with anthelminthic drugs in endemics areas for toxocariasis.en_US
dc.identifier.doi10.7417/CT.2013.1579
dc.identifier.endpage317en_US
dc.identifier.issn0009-9074
dc.identifier.issn1972-6007
dc.identifier.issue4en_US
dc.identifier.pmid24045514
dc.identifier.scopus2-s2.0-84884345641
dc.identifier.scopusqualityQ2
dc.identifier.startpage315en_US
dc.identifier.urihttps://doi.org/10.7417/CT.2013.1579
dc.identifier.urihttps://hdl.handle.net/11468/20407
dc.identifier.volume164en_US
dc.identifier.wosWOS:000329500300008
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSoc Editrice Univen_US
dc.relation.ispartofClinica Terapeutica
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChronic Utricariaen_US
dc.subjectElisaen_US
dc.subjectFasciola Speciesen_US
dc.subjectSeroprevalenceen_US
dc.subjectToxocara Canisen_US
dc.titleSeroprevalence of IgG anti-Toxocara canis antibodies and anti-Fasciola sp antibodies in patients with urticariaen_US
dc.titleSeroprevalence of IgG anti-Toxocara canis antibodies and anti-Fasciola sp antibodies in patients with urticaria
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu